News - Meda


Current filters:


Popular Filters

Sweden’s Meda rejects Mylan’s takeover overture

Sweden’s Meda rejects Mylan’s takeover overture


After a day of rumor and speculation about a takeover approach from US generic firm Mylan, Swedish drugmaker…

GenericsMedaMergers & AcquisitionsMylan Laboratories

Meda acquires US respiratory company


Swedish drugmaker Meda (STO:MEDAA) has signed an agreement to acquire the US development company Acton…

Acton PharmaceuticalsAerospan HFAFlunisolideMedaMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Meda expands collaboration with India's Cipla on Dymista


Swedish drugmaker Meda (OMX: MEDA A) is broadening its collaboration with Indian pharmaceutical company…

Asia-PacificCiplaDymistaLicensingMedaPharmaceuticalRespiratory and PulmonaryRest of the WorldSouth America

US FDA lowers recommended dose for sleep drugs containing zolpidem


The US Food and Drug Administration yesterday announced it is requiring the manufacturers of Ambien,…

AmbienAmbien CREdluarMedaNeurologicalNorth AmericaNovaDel PharmaPharmaceuticalRegulationSanofizolpidemZolpiMist

Jazz Pharma sells women's health business to Meda for $95 million


US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced a definitive agreement to sell its women's…

Jazz PharmaceuticalsMedaMergers & AcquisitionsPharmaceuticalWomen's Health

Meda's Zyclara approved in the EU


Sweden-based Meda (OMX: MEDA A) yesterday announced that the European Commission has granted marketing…


Perrigo confirms ANDA filing for generic Astepro nasal spray


US generic drugmaker Perrigo (Nasdaq: PRGO;TASE) says that it has filed an Abbreviated New Drug Application…

AsteproAzelastine HydrochlorideGenericsImpax LaboratoriesLegalMedaNorth AmericaPatentsPerrigoRegulationRespiratory and Pulmonary

EU Commission clears KKR acquisition of Pfizer Capsugel unit; Meda says no approach from Valeant


Under European Union merger regulations, the European Commission has cleared the proposed acquisition…

CapsugelMedaMergers & AcquisitionsPfizerPharmaceuticalValeant Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top